NEW YORK (GenomeWeb News) – Oxford Gene Technology said today that it has been working with Emory Genetics Laboratory to develop a menu of comparative genomic hybridization arrays focused on a variety of genetic disorders.

Together, the Oxford, UK-based company and EGL have designed more than 20 such chips, which enable the detection of copy number variants in genes associated with cardiovascular, inherited eye, intellectual disability, and neuromuscular disorders, as well as a range of inherited cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: method to detect single-nucleotide and copy-number alterations in single cells from archival tissue, and more.

China has announced new rules governing the use of stem cell treatments, Nature News reports.

Wired's Sarah Zhang expresses frustration as a microbiome study of homes uncovers expected bacteria.

A database containing genome sequences from strains of foodborne pathogens may enable regulators and companies to quickly identify outbreak sources, Reuters reports.